These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16894087)
1. Laboratory testing for drug abuse. Warner EA; Friedmann PD Arch Pediatr Adolesc Med; 2006 Aug; 160(8):854, author reply 854. PubMed ID: 16894087 [No Abstract] [Full Text] [Related]
2. Results of random drug testing in an adolescent substance abuse program. Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828 [TBL] [Abstract][Full Text] [Related]
3. Identification and quantitation of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in human urine by 1H NMR spectroscopy. Application to five cases of intoxication. Liu J; Decatur J; Proni G; Champeil E Forensic Sci Int; 2010 Jan; 194(1-3):103-7. PubMed ID: 19926414 [TBL] [Abstract][Full Text] [Related]
4. Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys. Melanson SE; Baskin L; Magnani B; Kwong TC; Dizon A; Wu AH Arch Pathol Lab Med; 2010 May; 134(5):735-9. PubMed ID: 20441504 [TBL] [Abstract][Full Text] [Related]
5. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005. Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145 [TBL] [Abstract][Full Text] [Related]
6. [Analyses of narcotics in urine--valuable if correctly done and competently used]. Edhag O Lakartidningen; 1991 Oct; 88(40):3261. PubMed ID: 1943333 [No Abstract] [Full Text] [Related]
7. Cut-off and toxicity levels for drugs-of-abuse testing. MLO Med Lab Obs; 2000 Aug; 32(8 Suppl):40-1. PubMed ID: 11183960 [No Abstract] [Full Text] [Related]
9. Is quantitative urinalysis more sensitive? Li SH; Chiang N; Tai B; Marschke CK; Hawks RL NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804 [No Abstract] [Full Text] [Related]
10. Clinical and professional reference guides. Cut-off and toxicity levels for drugs-of-abuse testing. Williams RA MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):16-7. PubMed ID: 11571830 [No Abstract] [Full Text] [Related]
12. A shortcoming you need to know about. Med Econ; 2004 May; 81(9):65-7. PubMed ID: 15164650 [No Abstract] [Full Text] [Related]
13. Roadside drug testing: unanswered questions and future challenges. Lenné MG Drug Alcohol Rev; 2007 Mar; 26(2):107-8. PubMed ID: 17364844 [No Abstract] [Full Text] [Related]
14. Informed consent: hospitals must obtain informed consent prior to drug testing pregnant patients. Gehringer K J Law Med Ethics; 2003; 31(3):455-7. PubMed ID: 14626554 [No Abstract] [Full Text] [Related]
15. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing. Andersson M; Gustavsson E; Stephanson N; Beck O J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):22-8. PubMed ID: 18088576 [TBL] [Abstract][Full Text] [Related]
16. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine. Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356 [TBL] [Abstract][Full Text] [Related]